| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |